Seven simple saves to improve your diet
We’ve all looked at the scale and winced. The urge to jump into a drastic diet might be overwhelming. Some changes to your eating habits can help you drop pounds…
Athletic teen’s remarkable journey through Adolescent and Young Adult (AYA) cancer treatment
When cancer attacks adolescents and young adults (AYA), the challenges it presents are different than for children or adults. The National Cancer Institute defines this “AYA” cohort as between the…
Tips to manage holiday stress
The holiday season is supposed to be the most wonderful time of the year, but it can be stressful sometimes. It often brings extra social and financial obligations; a breakdown…
10/24/18 112148 -- San Antonio, TX --- © Copyright 2018 Mark C. Greenberg for University Health System
Cynthia Blanco, M.D. poses with Jeylin Garza and her family for a photo during an event celebrating the premature babies, their families and NICU team members who participated in a clinical trial of Omegaven, a fish oil supplement given through IV to tiny babies with gastrointestinal complications.
Garza was among a group of premature babies and their families that participated in the trial that along with other studies led to the FDA approval of this life saving treatment for babies all across the country.
How determination made fish oil an FDA-approved medicine for babies
Dr. Cynthia Blanco’s passion to save babies was the key driver in the recent approval of Omegaven, a lifesaving fish oil treatment for babies with gastrointestinal complications. Blanco’s study followed…
Do I have a fatty liver?
A disease you may never have heard of is slowly damaging the health of a quarter of Americans. In San Antonio and the Valley, fatty liver disease affects nearly half…